Clinical Trial Update: Dialysate Sodium Lowering Trial [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating lower dialysate sodium in hemodialysis patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dialysis Disequilibrium
• Fluid Overload
• Hemodialysis Complication
• Hypertension
• Intra-dialytic Hypotension

Snippet

Sponsor: Tufts Medical Center | Conditions: Hemodialysis Complication, Fluid Overload | Phase 2 | Status: COMPLETED